Altered DNA Repair Pathway Engagement by Engineered CRISPR-Cas9 Nucleases

Invention type: Technology / Case number: #23588
License tlo.mit.edu/contact-us

Researchers

Vikash Chauhan / Robert Langer / Phillip Sharp

Departments: David H Koch Institute for Integrative Cancer Res, Office of the Institute Professors
Technology Areas: Biotechnology: DNA & RNA Editing, Synthetic Biology / Drug Discovery and Research Tools: Genomics & Proteomics
Impact Areas: Healthy Living

  • engineered nucleases and methods of use thereof
    United States of America | Published application
  • engineered nucleases and methods of use thereof
    Patent Cooperation Treaty | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Contact Us

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up

More Technologies

Multisensory Gamma Stimulation Promotes Glymphatic Clearance of Amyloid

#25696PH
Li-Huei Tsai / Edward Boyden / Ping-Chieh Pao / Cheng-Yi Yang / Mitchell Murdock
Biotechnology / Drug Discovery and Research Tools

Tuning Chloroplast Transgene Expression from Synthetic Operon

#25494
Christopher Voigt / Qiguo Yu
Agriculture & Food / Biotechnology / Therapeutics

A Multi-Pathway Reporter System that Interrogates Repair of DNA Double-Strand Breaks with Applications for Diagnosis and Therapeutic Treatment of Cancer and Neurodegenerative Diseases

#25444
Alex Kruswick / Michael Yaffe
Biotechnology / Diagnostics / Drug Discovery and Research Tools